Filing Details
- Accession Number:
- 0001209191-19-043685
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-30 16:48:46
- Reporting Period:
- 2019-07-26
- Accepted Time:
- 2019-07-30 16:48:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1446847 | Ironwood Pharmaceuticals Inc | IRWD | Pharmaceutical Preparations (2834) | 043404176 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601360 | E Halley Gilbert | C/O Ironwood Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Chief Admin Officer & Svp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2019-07-26 | 20,000 | $4.88 | 260,169 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2019-07-26 | 20,000 | $10.00 | 240,169 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-07-26 | 20,000 | $4.88 | 20,000 | $4.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,472 | 2019-07-28 | No | 4 | M | Direct |
Footnotes
- The reporting person acquired 1,929 shares of Class A common stock under the issuer's employee stock purchase plan on June 28, 2019.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.80 to $10.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The option vested as to 20,000 shares of Class A Common Stock upon the issuer's achievement of a commercial milestone on January 4, 2017. The remainder of the option expired on July 28, 2019.
Billionaire Hedge Funds
